These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15187531)

  • 1. The cost-effectiveness of proton pump inhibitors for bleeding peptic ulcers: The unanswered questions.
    Devlin JW; Welage LS
    Crit Care Med; 2004 Jun; 32(6):1415-6. PubMed ID: 15187531
    [No Abstract]   [Full Text] [Related]  

  • 2. High-dose intravenous proton pump inhibition following endoscopic therapy in the acute management of patients with bleeding peptic ulcers in the USA and Canada: a cost-effectiveness analysis.
    Barkun AN; Herba K; Adam V; Kennedy W; Fallone CA; Bardou M
    Aliment Pharmacol Ther; 2004 Mar; 19(5):591-600. PubMed ID: 14987328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial: Intravenous Proton Pump Inhibitors for Bleeding Peptic Ulcer: What is the Most Cost-Effective Approach?
    Peterson K; Bjorkman DJ
    Am J Gastroenterol; 2016 Oct; 111(10):1399-1401. PubMed ID: 27694876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are higher doses of proton pump inhibitors better in acute peptic bleeding?
    Villalón A; Olmos R; Rada G
    Medwave; 2016 Jun; 16 Suppl 2():e6476. PubMed ID: 27390875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of proton pump inhibitor therapy for acute peptic ulcer-related bleeding.
    Erstad BL
    Crit Care Med; 2004 Jun; 32(6):1277-83. PubMed ID: 15187506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton pump inhibitor dose for ulcer bleeding: is less really more?
    Leontiadis GI; Howden CW
    Arch Intern Med; 2010 Oct; 170(18):1697-8; author reply 1700. PubMed ID: 20937932
    [No Abstract]   [Full Text] [Related]  

  • 7. Proton pump inhibitors after endoscopy in peptic ulcer bleeding.
    Lin HJ
    Am J Gastroenterol; 2009 Jun; 104(6):1595; author reply 1595-6. PubMed ID: 19491877
    [No Abstract]   [Full Text] [Related]  

  • 8. High or low doses of PPIs for patients with peptic ulcer bleeding?
    Lin HJ
    Arch Intern Med; 2010 Oct; 170(18):1699-700; author reply 1700. PubMed ID: 20937935
    [No Abstract]   [Full Text] [Related]  

  • 9. Review: in high-risk ulcers, intermittent and continuous PPI therapy do not differ for recurrent bleeding.
    Long M; Lichtenstein D
    Ann Intern Med; 2015 Jan; 162(2):JC8. PubMed ID: 25599368
    [No Abstract]   [Full Text] [Related]  

  • 10. Outcomes of peptic ulcer bleeding following treatment with proton pump inhibitors in routine clinical practice: 935 patients with high- or low-risk stigmata.
    Lanas A; Carrera-Lasfuentes P; García-Rodríguez LA; García S; Arroyo-Villarino MT; Ponce J; Bujanda L; Calleja JL; Polo-Tomas M; Calvet X; Feu F; Perez-Aisa A
    Scand J Gastroenterol; 2014 Oct; 49(10):1181-90. PubMed ID: 25144754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acid inhibition and peptic ulcer bleeding.
    Štimac D; Franjić N; Krznarić Ž
    Dig Dis; 2011; 29(5):494-8. PubMed ID: 22095017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost implications of administering intravenous proton pump inhibitors to all patients presenting to the emergency department with peptic ulcer bleeding.
    Gagnon YM; Levy AR; Eloubeidi MA; Arguedas MR; Rioux KP; Enns RA
    Value Health; 2003; 6(4):457-65. PubMed ID: 12859587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermittent bolus or continuous infusion of proton pump inhibitors for ulcer bleeding?
    Hsu YC; Lin HJ
    JAMA Intern Med; 2015 Mar; 175(3):461. PubMed ID: 25730565
    [No Abstract]   [Full Text] [Related]  

  • 14. [Proton pump inhibitors prevent drug-induced bleeding ulcers].
    Søberg T
    Tidsskr Nor Laegeforen; 2012 May; 132(10):1208-9. PubMed ID: 22669376
    [No Abstract]   [Full Text] [Related]  

  • 15. Cost-effectiveness of intravenous proton pump inhibitors in high-risk bleeders.
    van Zanten SV
    Can J Gastroenterol; 2004 Dec; 18(12):749-50. PubMed ID: 15605141
    [No Abstract]   [Full Text] [Related]  

  • 16. It is premature to recommend low-dose intravenous proton pump inhibition after endoscopic hemostasis in patients with bleeding ulcers.
    Barkun AN; Kuipers EJ; Sung JJ
    Am J Gastroenterol; 2009 Aug; 104(8):2120-1. PubMed ID: 19661947
    [No Abstract]   [Full Text] [Related]  

  • 17. Meta-analysis: comparison of oral vs. intravenous proton pump inhibitors in patients with peptic ulcer bleeding.
    Tsoi KK; Hirai HW; Sung JJ
    Aliment Pharmacol Ther; 2013 Oct; 38(7):721-8. PubMed ID: 23915096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacological treatment of bleeding peptic ulcer].
    Gisbert JP
    Med Clin (Barc); 2006 Jun; 127(2):66-75. PubMed ID: 16801006
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypoalbuminemia is a predictor of mortality and rebleeding in peptic ulcer bleeding under proton pump inhibitor use.
    Cheng HC; Yang EH; Wu CT; Wang WL; Chen PJ; Lin MY; Sheu BS
    J Formos Med Assoc; 2018 Apr; 117(4):316-325. PubMed ID: 28751088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intragastric pH with oral versus intravenous bolus plus infusion proton pump inhibitor therapy in patients with bleeding ulcers.
    Lin HJ; Tsai JJ
    Gastroenterology; 2008 Nov; 135(5):1804-5. PubMed ID: 18840442
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.